|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
7 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||
| Loss from equity method investment in Operating Partnership | |||
| Cash flows from investing activities: | |||
| Investment in Operating Partnership | |||
| Proceeds from redemptions from Operating Partnership | |||
| Distributions from investment in Operating Partnership | |||
| Due from Operating Partnership | |||
| Distributions from Operating Partnership for offering costs | |||
| Net cash flows used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of common stock | |||
| Proceeds from the distribution reinvestment plan | |||
| Shares repurchased | |||
| Payment of offering costs | |||
| Distributions paid to common stockholders | |||
| Net cash flows provided by financing activities | |||
| Net change in cash and cash equivalents | |||
| Cash and cash equivalents, at beginning of the period | |||
| Cash and cash equivalents, at end of the period | |||
| Supplemental schedule of non-cash investing and financing activities: | |||
| Distributions payable | |||
| Distribution reinvestment and investment in Operating Partnership | |||
| Equity-based compensation - Restricted stock issued and investment in Operating Partnership | |||
| Accrued distribution fee due to related party |
Loading...
